The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate ...

Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced ...

Alkermes (ALKS) shifts to fully integrated biopharma, leveraging Vibrance-2, Lybalvi growth, and Avadel buy to de-risk ...

A study from MoneySuperMarket used 27,000 reviews to determine the airlines with the best food. The top 20 carriers hailed ...

Atea continues to advance its global Phase 3 program evaluating the fixed-dose combination (FDC) of BEM, a nucleotide analog ...

Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespect ...

It sounds like Lilly did just that. The U.S. pharma announced on Wednesday that it was paying $14 per share of Ventyx—more ...

Navodaya Vidyalaya Samiti has released NVS Class 9 LEST Admit Card 2026. Candidates who will appear for Class 9 Lateral Entry Selection Test can find the admit card link on the official website of NVS ...

Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...

The Sycamore Youth Center has announced registration is open for after-school classes for the winter and spring semester. Classes run from Jan. 26 through May 1, with courses offered to students in ...

From healthy exam habits to chapter-wise preparation, paper-presentation tips, and an effective time-management plan, here’s ...

The chief medical officer is interested in an easier path to market for health screening features in wearable devices.